MyRealWorld logo

Understanding burden of illness, impact of diseases and treatments on quality of life, and size of eligible patient (sub)populations is increasingly important. But what is the best way to do this? We have harnessed digital technology to create a powerful real-world evidence platform to quantify patients’ experience of illnesses and treatments. We can adapt data collection and synthesis to payer expectations and your market access requirements.

The benefits

  • Tailored data capture and evidence generation (e.g. PROs and treatment patterns)

  • Bring your own device (BYOD) technology; any device, any language, any country

  • Real-time data access

  • Industry-standard data security

  • Powerful patient interface, including SMS, email and fully electronic screening and consent

The platform



Rapid and secure administration of informed consent, plus generic and indication-specific PRO instruments, with our BYOD platform.

Prostate Cancer Case Study

We have recently used the platform to collect PRO data from patients being treated for hormone-resistant prostate cancer at several UK hospitals, in order to understand their experience of the disease.


Participants gave informed consent and completed the EORTC QLQ-C30/PR-25 and EQ-5D using mobile devices.


The team tailored patient communication using the platform’s inbuilt email and SMS systems.


Patients found the process quick and easy; the clinical staff loved the access to real-time data.